T. N. Seyfried and L. M. Shelton, Cancer as a metabolic disease, Nutr. & Metab, vol.7, 2010.

R. A. Gatenby, Is the Genetic Paradigm of Cancer Complete?, Radiology, vol.284, pp.1-3, 2017.

H. Oppermann, A. D. Levinson, H. E. Varmus, L. Levintow, and J. M. Bishop, Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src), Proc. Natl. Acad. Sci. United States Am, vol.76, pp.1804-1808, 1979.

E. S. Lander, Initial sequencing and analysis of the human genome, Nature, vol.409, pp.860-921, 2001.

D. Hanahan and R. A. Weinberg, The hallmarks of cancer, Cell, vol.100, pp.57-70, 2000.

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011.

F. Balkwill and A. Mantovani, Inflammation and cancer: back to Virchow?, Lancet, vol.357, pp.539-545, 2001.

M. Abolhassani, Hyperosmolarity causes inflammation through the methylation of protein phosphatase 2a, Inflamm. Res. Off. J. Eur. Histamine Res. Soc. et al, vol.57, pp.419-429, 2008.

M. Abolhassani, A. Guais, P. Chaumet-riffaud, A. J. Sasco, and L. Schwartz, Carbon dioxide inhalation causes pulmonary inflammation, Am. J. Physiol. Lung Cell. Mol. Physiol, vol.296, pp.657-665, 2009.

L. Schwartz, Hyperosmotic stress contributes to mouse colonic inflammation through the methylation of protein phosphatase 2a, Am. J. Physiol. Gastrointest. Liver Physiol, vol.295, pp.934-941, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00858998

L. Schwartz, A. Guais, M. Pooya, and M. Abolhassani, Is inflammation a consequence of extracellular hyperosmolarity?, J. Inflamm, 2009.

M. Israël and L. Schwartz, The metabolic advantage of tumor cells, Mol. Cancer, vol.10, 2011.

M. Israël, A possible primary cause of cancer: deficient cellular interactions in endocrine pancreas, Mol. Cancer, vol.11, 2012.

M. Israel, Comment on cancer metabolism and on the role of the endocrine pancreas, J. Clin. Medicine Res, vol.6, pp.490-491, 2014.

O. Warburg, F. Wind, and E. Negelein, The Metabolism Of Tumors In The Body, The J. Gen. Physiol, vol.8, pp.519-530, 1927.

O. Warburg, On the origin of cancer cells. Sci, vol.123, pp.309-314, 1956.

R. A. Gatenby and B. R. Frieden, Information dynamics in carcinogenesis and tumor growth, Mutat. Res, vol.568, pp.259-273, 2004.

R. J. Deberardinis, N. Sayed, D. Ditsworth, and C. B. Thompson, Brick by brick: metabolism and tumor cell growth, Curr. Opin. Genet. & Dev, vol.18, pp.54-61, 2008.

G. Kroemer and J. Pouyssegur, Tumor cell metabolism: cancer's Achilles' heel, Cancer Cell, vol.13, p.5, 2008.

J. Da-veiga-moreira, Cell cycle progression is regulated by intertwined redox oscillators, Theor. Biol. Med. Model, vol.12, 2015.

L. Schwartz, A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results, Oncol. Reports, vol.23, pp.1407-1416, 2010.

G. Hatzivassiliou, ATP citrate lyase inhibition can suppress tumor cell growth, Cancer Cell, vol.8, pp.311-321, 2005.

S. Bonnet, An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension, Circulation, vol.113, pp.2630-2641, 2006.

A. Guais, Adding a combination of hydroxycitrate and lipoic acid (METABLOCTM) to chemotherapy improves effectiveness against tumor development: experimental results and case report, Investig. New Drugs, vol.30, 2012.

M. Abolhassani, Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice, Investig. New Drugs, vol.30, pp.1331-1342, 2012.

J. M. Evans, L. A. Donnelly, A. M. Emslie-smith, D. R. Alessi, and A. D. Morris, Metformin and reduced risk of cancer in diabetic patients, BMJ, vol.330, pp.1304-1305, 2005.

I. B. Sahra, Y. L. Marchand-brustel, J. Tanti, and F. Bost, Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?, Mol. Cancer Ther, vol.9, pp.1092-1099, 2010.

C. Loubiere, B. Dirat, J. Tanti, and F. Bost, Metformine et cancer: passé, présent, avenir, vol.3, pp.205-213, 2014.

G. Libby, New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes, Diabetes Care, vol.32, pp.1620-1625, 2009.

K. Krisztina, M. Aune, S. James, E. Guido, and R. Enrique, Metformin Inhibits the Growth of Human Pancreatic Cancer Xenografts, Pancreas, vol.42, pp.781-785, 2013.

E. Gottfried, New aspects of an old drug-diclofenac targets MYC and glucose metabolism in tumor cells, PloS One, vol.8, 2013.

N. Mayorek, N. Naftali-shani, and M. Grunewald, Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity, PloS One, vol.5, 2010.

M. S. Al-nimer, H. G. Hameed, and M. M. Mahmood, Antiproliferative effects of aspirin and diclofenac against the growth of cancer and fibroblast cells: In vitro comparative study. Saudi, Pharm. J, vol.23, pp.483-486, 2015.

J. Robitaille, J. Chen, and M. Jolicoeur, A Single Dynamic Metabolic Model Can Describe mAb Producing CHO Cell Batch and Fed-Batch Cultures on Different Culture Media, PloS One, vol.10, 2015.

J. Da-veiga-moreira, The Redox Status of, Cancer Cells Supports Mechanisms behind the Warburg Effect. Metabolites, vol.6, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01417967

A. Ghorbaniaghdam, O. Henry, and M. Jolicoeur, A kinetic-metabolic model based on cell energetic state: study of CHO cell behavior under Na-butyrate stimulation, Bioprocess Biosyst. Eng, vol.36, pp.469-487, 2013.

A. Ghorbaniaghdam, J. Chen, O. Henry, and M. Jolicoeur, Analyzing clonal variation of monoclonal antibody-producing CHO cell lines using an in silico metabolomic platform, PloS One, vol.9, 2014.

A. Ghorbaniaghdam, O. Henry, and M. Jolicoeur, An in-silico study of the regulation of CHO cells glycolysis, J. Theor. Biol, vol.357, pp.112-122, 2014.

G. Goffaux, I. Hammami, and M. Jolicoeur, A Dynamic Metabolic Flux Analysis of Myeloid-Derived Suppressor Cells Confirms Immunosuppression-Related Metabolic Plasticity, Sci. Reports, vol.7, 2017.

S. Klamt and E. Gilles, Minimal cut sets in biochemical reaction networks, Bioinformatics, vol.20, pp.226-234, 2004.

S. Klamt, J. Saez-rodriguez, and E. Gilles, Structural and functional analysis of cellular networks with cellnetanalyzer, BMC Syst. Biol, vol.1, 2007.

A. Von-kamp, S. Thiele, O. Hädicke, and S. Klamt, Bioinformatics Solutions for Big Data Analysis in Life Sciences presented by the German Network for, J. Biotechnol, vol.261, pp.221-228, 2017.